News Headlines Article

Gilead’s CFO to step down early next year
San Francisco Business Times

Foster City-based Gilead Sciences’ longtime chief financial officer is planning her exit.

Robin Washington, the biopharmaceutical giant’s executive vice president and CFO, intends to retire from her role by March 1, 2020, the company said.

“During my short time here, I have been impressed with the strategic expertise that Robin brings to her role and the dedication she has for our mission and the patients we serve,” said Daniel O’Day, who started at Gilead as chairman and CEO earlier this year, in a statement. “It is equally clear that she has built a strong team across the organizations she leads.”